Trial intelligence / Profile preview

Single-dose prednisolone for cellulitis in the emergency department

ACTRN12619000888167Phase 4Not yet recruiting

Sponsor
Wide Bay Hospital and Health Service
Start
Jul 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cellulitis comparing Prednisolone + standard antibiotics with Placebo + standard antibiotics (2 arms). Primary endpoint: Time to resolution of cellulitis symptoms. Planned start Jul 2019; status: not yet recruiting.

02

Drugs

prednisolone
03

Conditions

cellulitis

Beyond the preview

Go deeper on ACTRN12619000888167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12619000888167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call